From the Desk of the CEO

Pneumonia remains the most common infection-related condition that lands U.S. patients in the hospital. Identifying strategies to curb antibiotic overuse for those hospitalized with pneumonia continues to be a national priority.

Results of a new study published in NEJM found that semaglutide led to greater reductions in weight loss and heart failure–related symptoms in patients who had obesity-related heart failure with preserved ejection fraction and T2D compared with placebo.

Biosimilars have typically been viewed as cost-saving medications, but according to results of a study published in JAMA Health Forum, biosimilar competition did not consistently lower out-of-pocket costs for outpatients who were commercially insured. In fact, in some cases, costs even increased.

Authors of a new study said that “d-Mannose should not be recommended to prevent future episodes of medically attended UTI in women with recurrent UTI in primary care.”

The New York State Department of Health issued an order in late March to formally implement a new law establishing access to hormonal contraception from pharmacists without a physician’s order.